Clinical Trials

Showing trials with last updates posted in 2026.

NCT05997056 | COMPLETED | PHASE2
12 participants

Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-25
Start Date:
2023-10-20
Completion:
2025-10-03
Conditions
  • Neuroendocrine Tumors
  • NET
  • Pancreatic Neuroendocrine Tumor
  • Gastrointestinal Neuroendocrine Tumor
  • Pulmonary Neuroendocrine Tumor
Interventions
  • DRUG
NCT05992415 | NOT_YET_RECRUITING | NA
7085 participants

Know Your Pressures NYC

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-25
Start Date:
2027-07-01
Completion:
2032-06-30
Conditions
  • Glaucoma
  • Hypertension
  • Glaucoma, Suspect
  • Elevated Blood Pressure
Interventions
  • OTHER
No Results Yet
NCT05886049 | RECRUITING | PHASE1
38 participants

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-25
Start Date:
2024-06-20
Completion:
2027-12-31
Conditions
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia With KMT2A Rearrangement
  • Acute Myeloid Leukemia With NPM1 Mutation
  • Secondary Acute Myeloid Leukemia
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT05761171 | ACTIVE_NOT_RECRUITING | PHASE2
78 participants

A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-25
Start Date:
2024-01-08
Completion:
2027-12-31
Conditions
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • Recurrent Acute Lymphoblastic Leukemia
  • Recurrent Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage
  • Recurrent Acute Myeloid Leukemia Due to Lineage Switch From B Acute Lymphoblastic Leukemia, KMT2A-Rearranged
  • Recurrent Acute Myeloid Leukemia Due to Lineage Switch From Mixed Phenotype Acute Leukemia
  • Recurrent Mixed Phenotype Acute Leukemia
  • Refractory Acute Leukemia of Ambiguous Lineage
  • Refractory Acute Lymphoblastic Leukemia
  • Refractory Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage
  • Refractory Acute Myeloid Leukemia Due to Lineage Switch From B Acute Lymphoblastic Leukemia, KMT2A-Rearranged
  • Refractory Acute Myeloid Leukemia Due to Lineage Switch From Mixed Phenotype Acute Leukemia
  • Refractory Mixed Phenotype Acute Leukemia
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT05677100 | RECRUITING | NA
320 participants

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-25
Start Date:
2023-08-23
Completion:
2028-01-31
Conditions
  • Heart Failure
  • Cardiorenal Syndrome
  • Cardio-Renal Syndrome
  • ADHF
  • Heart Failure, Systolic
  • Heart Failure, Diastolic
  • Heart Failure; With Decompensation
  • Heart Failure, Congestive
Interventions
  • DEVICE
No Results Yet
NCT05663931 | ACTIVE_NOT_RECRUITING | NA
120 participants

Diabetes Toolkit at Discharge

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-25
Start Date:
2024-08-20
Completion:
2026-05-01
Conditions
  • Diabetes Mellitus, Type 2
  • Insulin Dependent Diabetes
Interventions
  • OTHER
No Results Yet
NCT05504291 | RECRUITING | PHASE2
26 participants

A Study to Give Treatment Inside the Eye to Treat Retinoblastoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-25
Start Date:
2022-11-04
Completion:
2028-03-31
Conditions
  • Bilateral Retinoblastoma
  • Childhood Intraocular Retinoblastoma
  • Group D Retinoblastoma
  • Stage I Retinoblastoma
  • Unilateral Retinoblastoma
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page